HASBROUCK HEIGHTS, N.J.--(BUSINESS WIRE)--Nymox Pharmaceutical Corporation (NASDAQ:NYMX) announced today that the Company will present at the 2008 Growth & Value Investor Conference to be held in at the Westin Fort Lauderdale, Fort Lauderdale, FL on February 27 and 28. At the Conference, the Company’s CEO, Paul Averback, MD, will provide an overview of the Company’s recent progress in drug development. The Growth & Value Investor Conference is hosted by LDV Capital Management in cooperation with the Stock and Bond Club of South Florida and is expected to attract 1,000 to 1,500 investment professionals.
